How does Mounjaro compare to other GLP-1 agonists?
Mounjaro is generally more effective for weight loss than other GLP-1 agonists like Ozempic, with studies showing people can lose up to 22.5% of their starting body weight over 72 weeks when combined with healthy eating and exercise, compared to around 15% with Ozempic. Mounjaro works by reducing appetite, making it easier to stick to a lower-calorie diet, and is officially approved for weight loss in the UK. However, results vary from person to person, and maintaining lifestyle changes is important for long-term success.
- Mounjaro can help people lose up to 22.5% of their body weight over 72 weeks.
- Ozempic typically results in about 15% weight loss over a similar period.
- Mounjaro is approved for weight loss in the UK, giving it a regulatory advantage.
- Weight loss is most effective when combined with diet and exercise changes.
- Individual results may vary, and stopping Mounjaro can lead to regaining some weight.
This text has been fact-checked for accuracy by Sorin Romaniuc, Pharmacist at medino.